选择了SUNGO作为美代的您可以享受到如下星级服务: 1. FDA注册的日常维持,更新; 2. FDA新动态的时间告知及建议; 3. 随时为您提供与FDA注册和上市后监管等相关的事务的处理意见; 4.可代表您回答您美国客户的相关FDA问题(英文邮件,英文电话会议均可); 5.接受FDA验厂时,以优惠的价格提供QSR820、审核经验传授及全程英语陪审 6.选择有能力进行QSR820(包括美国法规知识、国内审核经验和英语沟通能力)的美国代理人! 7.在完成注册后,启动QSR820体系,按照美国法规的要求实施管理,有备无患! 8.实在没有满足第2条又被抽查到,立即联系我们,为你提供五天方案审查!
![美国代理人](http://static.11467.com/img/lazy.gif)
FDA 化妆品注册怎么做? FDA化妆品注册(138电181话046微17信) • 1/ 化妆品企业注册可以在出口美国之前或者出口之后(30天内); • 2/ 化妆品产品注册需要有1000美金的出口之后,但是实际上FDA无法核对; • 3/ Can I file formulations in the VCRP for products that are considered drugs but also have a cosmetic function? 对于药品有化妆品功能的是否可以做化妆品注册? • Yes, products that are considered drugs in the United States, such as sunscreens, but also make cosmetic type claims, such as moisturizing, can be filed in the VCRP. • 4/ 可以进行化妆品注册,但是这并不能豁免其需要同时满足药品的相关要求的职责。
![美国代理人](http://static.11467.com/img/lazy.gif)
每年更新FDA 要求: • 1) 注册和登记每年要更新一次(更新时间是:10月1号到12月31号 • 2) 要随时通知FDA注册和登记内容的变化。 – II 类产品,在进行设施登记和器械注册后,还需递交“上市前通知” 即510(K)申请。只有个别产品510(K) 豁免。
![美国代理人](http://static.11467.com/img/lazy.gif)
FDA对于美国代理人的解释也可以参考看一下网站的原文: Any foreign establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device imported into the United States must identify a United States agent (U.S. agent) for that establishment. Information about a foreign establishment’s U.S. Agent is submitted electronically using the FDA Unified Registration and Listing System (FURLS system) and is part of the establishment registration process. Each foreign establishment may designate only one U.S. agent. The foreign establishment may also, but is not required to, designate its U.S. agent as its official correspondent. The foreign establishment should provide the name, address, telephone and fax numbers, and e-mail address of the U.S. agent. The U.S. agent identified will be required to complete an automated process to confirm that they have agreed to act as the U.S. agent. The automated process will forward an email verification request to the U.S. agent. They will be re to confirm her/his consent to act as a representative/liaison on behalf of the foreign establishment. If the U.S. agent denies consent (or does not respond within 10 business days), the Official Correspondent/Owner Operator of the foreign establishment will be notified and must designate a new U.S. agent to satisfy the regulatory obligation.